Consistent with published data (Sala et al., 2008; Tsai et al., 2008), PLX4032 abolished the ERK1/2 activating phosphorylation in BRAFV600E/K melanoma cells (Figure 2, pERK, YULAC, YURIF, YUMAC and YUGEN8). The gene discussed is EIF2AK3; the disease is melanoma.